Profiel
Michael E.
Markels worked as a Senior Director in Marketing at Biogen, Inc. in 2006.
He also worked as a Senior Director in Infectious Disease & Oncology at InterMune, Inc. in 2002.
From 1990 to 2001, he worked at Glaxo Wellcome, Inc. as a Director in Global Commercial Strategy.
He was also a Senior VP in Commercial & Business Development at NeurogesX, Inc. Mr. Markels holds an MBA from Duke University and an undergraduate degree from Colorado State University.
Eerdere bekende functies van Michael E. Markels
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOGEN INC. | Sales & Marketing | 01-05-2006 |
| INTERMUNE INC | Corporate Officer/Principal | 01-10-2002 |
| Glaxo Wellcome, Inc. | Corporate Officer/Principal | 01-01-2001 |
| NEUROGESX, INC | Corporate Officer/Principal | - |
Opleiding van Michael E. Markels
| Duke University | Masters Business Admin |
| Colorado State University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
InterMune, Inc.
 InterMune, Inc. BiotechnologyHealth Technology InterMune, Inc. operates as a biotechnology company that researches, develops and commercializes therapies in pulmonology and orphan fibrotic diseases. It focuses on therapies for the treatment of idiopathic pulmonary fibrosis, a progressive and fatal lung disease. The firms research programs are focused on the discovery of targeted, small-molecule therapeutics and biomarkers to treat and monitor serious pulmonary and fibrotic diseases. The company was founded in 1998 and is headquartered in South San Francisco, CA. | Health Technology |
NeurogesX, Inc.
 NeurogesX, Inc. Pharmaceuticals: MajorHealth Technology NeurogesX, Inc. developed and commercialized novel pain management therapies. The company was founded by Wendye R. Robbins on May 28, 1998 and was headquartered in San Mateo, CA. | Health Technology |
| Glaxo Wellcome, Inc. | Health Technology |
